Trial intelligence / Profile preview

Omnitrope in short children born SGA

NCT00537914Phase 4Completed

Sponsor
Sandoz
Start
Feb 2008
Primary completion
Mar 2022
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
7
01

Overview

A Phase 4 trial of somatropin in short stature, sponsored by Sandoz. Started Feb 2008; status: completed.

02

Drugs

somatropin
03

Conditions

short stature

Beyond the preview

Go deeper on NCT00537914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00537914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call